Non-homologous end joining (NHEJ) is a major pathway for the repair of DNA double-strand breaks in mammalian cells. DNA-dependent protein kinase (DNA-PK), ligase IV, and XRCC4 are all critical components of the NHEJ repair pathway. DNA-PK is composed of a heterodimeric DNA-binding component, Ku, and a large catalytic subunit, DNA-PKcs. Ligase IV and XRCC4 associate to form a multimeric complex that is also essential for NHEJ. DNA-PK and ligase IV/XRCC4 interact at DNA termini which results in stimulated ligase activity. Here we define interactions between the components of these two essential complexes, DNA-PK and ligase IV/XRCC4. We find that ligase IV/XRCC4 associates with DNA-PK in a DNA-independent manner. The specific protein-protein interactions that mediate the interaction between these two complexes are further identified. Direct physical interactions between ligase IV and Ku as well as between XRCC4 and DNA-PKcs are shown. No direct interactions are observed between ligase IV and DNA-PKcs or between XRCC4 and Ku. Our data defines the specific protein pairs involved in the association of DNA-PK and ligase IV/XRCC4, and suggests a molecular mechanism for coordinating the assembly of the DNA repair complex at DNA breaks.
Introduction
DNA damage occurs in all living cells and presents a major threat to the integrity of the genome. DNA double-strand breaks (DSBs) are particularly hazardous, as a single un-repaired break can be lethal to a cell, and incorrect repair can cause gross genetic rearrangements. Eukaryotic cells have evolved two major pathways for the repair of DNA double-strand breaks: nonhomologous end joining (NHEJ) and homologous recombination [1] . Both repair pathways require recognition of DSBs, localization of repair enzymes to the site of damage, DNA processing to yield ligatable termini, and finally ligation to reseal the break. The NHEJ pathway is strictly dependent upon functional DNA-PK, ligase IV, and XRCC4 [1] [2] [3] [4] [5] . The number of proteins and processes required to repair DSBs in mammalian cells suggests the existence of a mechanism for the temporal and spatial coordination of these proteins and processes.
The DNA-dependent protein kinase (DNA-PK) is a nuclear serine/threonine protein kinase and a key component of the mammalian NHEJ pathway [6, 7] . DNA-PK is a member of the phosphatidyl-inositol 3 kinase (PI 3-kinase) super-family of kinases and consists of a 460-kDa catalytic subunit (DNA-PKcs) and a DNA binding component (Ku) [8, 9] . Ku is a heterodimer comprised of 70-kDa (Ku70) and 80-kDa (Ku80) subunits and binds tightly to DNA termini in a sequence-independent manner. The high affinity of Ku 4 for DNA termini and its abundance in the nuclei suggest that Ku may be involved in early recognition of DSBs [10, 11] . The kinase activity of DNA-PK is dependent upon the assembly of DNA-PKcs with DNA-bound Ku, resulting in an active holo-enzyme/DNA complex [9] . Disruption of genes encoding DNA-PKcs, Ku70, or Ku80 results in severe defects in NHEJ and V(D)J recombination [3, 5, 12, 13] . Furthermore, catalytically inactive mutants of DNA-PKcs fail to complement deficiencies in DSB repair or V(DJ) recombination in DNA-PKcs deficient cells, indicating that the kinase activity of DNA-PK is required for mammalian NHEJ [13] . Although the requirement for DNA-PK and its kinase activity in NHEJ has been clearly established, the specific function(s) of DNA-PK in NHEJ remain unclear. DNA-PK may function as a DNA-damage sensor, its DNAbreak dependent activation triggering an intracellular signaling pathway through phosphorylation of specific target proteins. Alternatively, DNA-PK may act directly in NHEJ by functioning as a scaffold for assembly and coordination of the repair enzymes at DNA breaks.
Ligase IV and XRCC4 form hetero-multimers and ligase IV activity is stimulated by its association with XRCC4 [14] [15] [16] . Cells deficient in XRCC4 have significantly reduced levels of ligase IV, suggesting that ligase IV may require XRCC4 for its stability [17] . A functional ligase IV/XRCC4 complex is also required for the repair of DSBs via the NHEJ pathway [18, 19] . Several lines of evidence indicate that DNA-PK and ligase 5 IV/XRCC4 functionally interact during NHEJ. Cells lacking DNA-PKcs, Ku, ligase IV, or XRCC4 are all impaired in V(D)J recombination and are hypersensitive to irradiation [5, 20] . Direct interactions between ligase IV/XRCC4 and DNA-PK on DNA termini have been observed [21] . Additionally, Ku has been shown to stimulate ligase IV activity in vitro [22] , possibly due to its ability to tether two DNA termini. Furthermore, Ku has been reported to recruit ligase IV/XRCC4 to DNA ends via protein-protein interactions [23] , and XRCC4 can stimulate the assembly of the DNA-PK/DNA complex [24] .
Here we report that the ligase activity associated with DNA-PK in cellular extracts is primarily ligase IV, and not ligase I or ligase III. We further show that ligase IV interacts directly with Ku, and DNA-PK binds to XRCC4. These data suggest a possible mechanism for the coordination of repair enzyme assembly during NHEJ. 6
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Antibodies
Ku80 hybridoma was a gift from Dr. N.-H. Yeh (Yang-Ming University, Taiwan).
DNA-PKcs (25-4) monoclonal antibody was purchased from NeoMarkers (Fremont, CA). Rabbit α-XRCC4 antibodies were provided by S.P. Jackson (Cambridge University, UK) or purchased (SeroTec, UK). Non-immunized mouse or rabbit IgG was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit α-ligase IV antibody was raised against a recombinant fragment of ligase IV that was purified from E. coli.
Cell cultures 7
Human cervical carcinoma HeLa and malignant glioma M059J and M059K cells were propagated in RPMI 1640 medium (Gibco-BRL) supplemented with 10% fetal bovine serum (HyClone).
Protein purification
XRCC4 and ligase IV were co-expressed and purified from insect cells infected with recombinant baculovirus as described [14] . The baculoviral co-expressed Ku70/Ku80 was purified as described [25] . Ku and DNA-PKcs were purified from human placenta or HeLa cells as described [25, 26] .
In vitro transcription/translation
Ligase IV full-length cDNA was cloned into pET28a(+) (Novagen). Purified plasmid DNA was used for in vitro transcription/translation reactions with the TNT Coupled Reticulocyte Lysate System (Promega). Uncoupled radioactive materials were removed by passing through Nu-Clean D25 column (Shelton Scientific). 8 
Cell extracts and immunoprecipitation
Exponentially growing cells were trypsinized, washed twice with PBS, and lysed in buffer A (1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50 mM Tris-HCl pH 7.4, 1 mM DTT, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride) (3.5x10 7 cells/ml). After incubation for 30 min at 4 o C, cell lysates were clarified by centrifugation at 10,000 g for 10 min. As indicated, cell extracts were pretreated with ethidium bromide (EtBr) for 10 min at 4 o C followed by centrifugation . Antibodies were added to lysates for 4 hr at 4 o C with gentle agitation. Thirty microliters of UltraLink TM Immobilized Protein A/G beads (Pierce) was added to reaction mixtures and incubated for 1 hr at 4 o C.
The immunobeads were washed 5 times with NET buffer (0.5% NP-40, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 5 mM MgCl 2, 50 mM Tris-HCl pH 8.0) and rinsed once with reaction buffer.
Adenyl-ligase assay
Immune complexes were reacted for 30 min at 25 o C with 25 µl of ligation buffer containing 50 mM Tris-HCl pH 8.0, 10 mM MgCl 2 , 5 mM dithiothreitol, 2 µg of BSA, 2
µCi of [α-32 P]ATP (3000 Ci/mmol), and 0.25 mM ATP. Reactions were terminated by 9 adding 25 µl of 2x SDS sample buffer and heating at 95 o C for 5 min. Adenylated proteins were resolved by 7.5% SDS-PAGE and detected by autoradiography.
Preparation of oligo/polynucleotide substrates
Oligonucleotides (rA) 18 were synthesized. Oligonucleotides (dT) 16 , polynucleotides (rA), and polynucleotides (dT) were purchased (Amersham Pharmacia Biotech). Oligonucleotide (rA) 18 was mixed with an equimolar amount of polynucleotide (dT). Oligonucleotide (dT) 16 was mixed with an equimolar amount of polynucleotide (rA). The oligo/polynucleotide mixtures were incubated at 95 o C for 10 min and cooled slowly to room temperature to facilitate annealing.
De-adenylation of adenyl-ligase intermediates
The adenylation reactions were performed as described above, and then incubated with 1 µg of oligo(dT)-poly(rA) or oligo(rA)-poly(dT) substrates for 1 hr at 25 o C. The de-adenylation reactions were resolved by SDS-PAGE and detected by autoradiography. assembled on DNA beads. DNA-PK/DNA beads were separated by centrifugation and the free isotope was removed from the probes as described above. 
In vitro phosphorylation of Ku, XRCC4, XRCC4/ligase IV
In vitro co-immunoprecipitation assay
Far-Western analysis
Two hundred nanograms of purified BSA, human DNA-PKcs, and baculoviralexpressed Ku, XRCC4, and XRCC4/Ligase IV were spotted onto nitrocellulose. Filters were blocked in buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-20, and 5% non-fat dry milk for 1 hr. 32 P-Ku or 32 P-XRCC4 probes were reacted with the filters in blocking buffer containing 1% non-fat milk for 2 hours at 25 o C. Blots were washed 4 times for 10 min each in blocking buffer without milk. Hybridizing signals were detected by phosphor imaging.
Immunoblotting
Protein samples were heated with SDS sample buffer at 95 o C for 10 min, separated by SDS-PAGE, and electro-transferred onto a nitrocellulose membrane. Filters were blocked as described above, immunoblotted with primary antibodies, and subsequently probed with horseradish peroxidase-conjugated secondary antibodies. The antibody-reactive proteins were visualized by chemiluminescence (Amersham).
Results
DNA ligase IV co-immunoprecipitates with DNA-PK
To determine whether ligase activity is associated with DNA-PK, we (Fig. 1A) . The resulting immunoprecipitates were incubated with [α-32 P]-ATP, and resolved by SDS-PAGE. We observed ligase-AMP intermediates associated with XRCC4, Ku80, and DNA-PKcs having an approximate molecular mass of 110 kDa (Fig. 1A, lanes 3-5) .
Human ligase I, ligase III, and ligase IV have similar molecular masses (approximately 110 kDa), therefore the specific ligase associated with DNA-PK cannot be distinguished by electrophoretic mobility alone. However, these three ligases have differential substrate specificities and can be identified by their ability to join different 14 oligonucleotide substrates in vitro [28] . DNA ligase I will ligate oligo(rA)-poly(dT), DNA ligase III can join both oligo(rA)-poly(dT) and oligo(dT)-poly(rA), and DNA ligase IV is able to ligate oligo(dT)-poly(rA). In the presence of a suitable substrate, the respective ligase-AMP will catalyze DNA ligation and release the AMP (de-adenylation). and not with oligo(rA)-poly(dT). Hence, the ligase co-precipitated with DNA-PK is predominantly ligase IV.
DNA is not required for ligase IV association with DNA-PK
To determine whether DNA mediates the interaction between ligase IV/XRCC4 and DNA-PK, different concentrations of ethidium bromide (EtBr) were added to cell extracts to disrupt protein-DNA interactions [29, 30] . As shown in Fig. 2 , the association of ligase IV with Ku80, DNA-PKcs and XRCC4 persists in the presence of EtBr concentrations up to and including 400 µg/ml. In contrast, the association of Ku and DNA-PKcs is disrupted by the addition of EtBr, showing that EtBr at these concentrations can disrupt the DNA-dependent assembly of DNA-PK ( Fig. 2D and 2E ).
The interactions between ligase IV/XRCC4 and DNA-PK persist at EtBr concentrations that disrupt DNA-PK assembly, suggesting that ligase IV/XRCC4 and DNA-PK interactions are DNA-independent. Moreover, the ligase IV signal remains associated with both Ku and DNA-PKcs even at concentrations that disrupt the DNA-PK complex.
Thus, the ligase IV/XRCC4 complex is associated with both Ku and DNA-PKcs independently.
DNA-PKcs enhances ligase IV/XRCC4-Ku interactions in vivo
We next investigated how DNA-PKcs influences Ku association with ligase IV in vivo. Using human glioma cell lines M059J, deficient for DNA-PKcs, and M059K that expresses DNA-PKcs, we found that the relative levels of DNA-PKcs, Ku80, ligase IV, and XRCC4 proteins are not grossly different between these different cell lines (Fig. 3A ) [31] . As expected, ligase activity was not detected in DNA-PKcs immunoprecipitates from M059J cells (Fig. 3B, lane 5) . Approximately equal amounts of ligase activity were precipitated by α-XRCC4, indicating that the ligase IV/XRCC4 complex is intact and readily detectable in cells with or without DNA-PKcs protein (Fig. 3B, lanes 1 and 2) .
Interestingly, the ligase activity associated with Ku is approximately 10-fold greater in cells expressing DNA-PKcs than in cells lacking DNA-PKcs (Fig. 3B, lanes 3 and 4) .
The ligase activity co-precipitated with DNA-PKcs from the M059K cells is specifically ligase IV, as evaluated by substrate specific de-adenylation (Fig. 3C) . These results indicate that DNA-PKcs is either directly or indirectly influencing the ligase IV/XRCC4/Ku complex in vivo.
DNA-PKcs interacts with XRCC4, and Ku binds to ligase IV
To further define how ligase IV/XRCC4 interacts with the subunits of DNA-PK, immunoprecipitation assays were performed with purified component proteins.
Recombinant XRCC4 was radiolabeled in a kinase reaction by DNA-PK immobilized on DNA-agarose beads. The 32 P-XRCC4 was incubated with Ku, DNA-PKcs, or a mixture of Ku and DNA-PKcs, followed by immunoprecipitation with α-Ku or α-DNA-PKcs (Fig. 4A) . The radiolabeled XRCC4 associates with DNA-PKcs independent of Ku (Fig.   4A, lane 4) , while the association of XRCC4 with Ku is significantly greater in the presence of DNA-PKcs (Fig. 4A, lanes 3 and 5) . To further investigate the interactions between DNA-PK and ligase IV/XRCC4, we phospho-radiolabeled purified ligase IV/XRCC4 complex as above. The labeled ligase IV/ 32 P-XRCC4 was used in immunoprecipitation assays (Fig. 4B) . In contrast to 32 P-XRCC4 alone, ligase IV/ 32 P-XRCC4 shows significant association with both Ku and DNA-PKcs (Fig. 4B, lanes 3-5) .
These data show that DNA-PKcs and Ku can each independently interact with ligase IV/XRCC4, while XRCC4 alone associates with DNA-PKcs but not Ku. These results are consistent with the observed association of ligase IV with DNA-PKcs under conditions that dissociate DNA-PK ( Fig. 2D and 2E) . Taken together, these results suggest that Ku may interact specifically with the ligase IV component of the ligase IV/XRCC4 complex while DNA-PKcs interacts directly with XRCC4.
Far-Western analysis was carried out to further define the interactions between DNA-PK and ligase IV/XRCC4. Purified recombinant Ku and XRCC4 were phosphoradiolabeled in vitro by immuno-bead-coupled DNA-PK. These radiolabeled proteins were used to probe for direct interactions with immobilized XRCC4, ligase IV/XRCC4, bovine serum albumin (BSA), Ku, and DNA-PKcs . Consistent with the co-precipitation results, 32 P-XRCC4 interacts with immobilized XRCC4, ligase IV/XRCC4 and DNA-PKcs, but not with Ku (Fig. 5A ). The 32 P-Ku interacts with DNA-PKcs and the ligase IV/XRCC4 complex but exhibits no binding to purified XRCC4 alone ( Fig. 5B ), suggesting that Ku interacts with ligase IV.
To directly test whether Ku and ligase IV interact, ligase IV was translated in vitro with 35 S-methionine in the presence or absence of purified XRCC4. These reactions 18 resulted in 35 S-ligase IV and 35 S-ligase IV/XRCC4 complex. The translation products were incubated with Ku alone, DNA-PKcs alone, or a mixture of Ku, DNA-PKcs, and DNA (holo-DNA-PK). The reactions were then immunoprecipitated with antibody recognizing either Ku or DNA-PKcs (Fig. 5C ). Both 35 S-ligase IV and 35 S-ligase IV/XRCC4 complex were associated with holo-DNA-PK (Fig. 5C, lanes 1 and 5) . Ku alone also associated with ligase IV and the ligase IV/XRCC4 complex (Fig. 5C, lanes 2   and 6) . In contrast, 35 S-ligase IV/XRCC4 co-precipitated with DNA-PKcs while 35 Sligase IV alone failed to associate with DNA-PKcs (Fig. 5C, lanes 3 and 7) , indicating that ligase IV interacts with Ku and not with DNA-PKcs.
Discussion
In this report, we investigate ligase activity associated with DNA-PK in cellular extracts. Simultaneous detection of ligase I, ligase III, and ligase IV was made possible by the use of ligase-AMP intermediates for ligase detection. By discharging or deadenylating these intermediates with ligase-specific substrates, we find that the ligase activity associated with DNA-PK is almost exclusively ligase IV, and the other human ligases do not appreciably associate with DNA-PK in cellular extracts.
XRCC4, which forms a tight complex with ligase IV, is reported to have weak DNA binding activity, and the XRCC4 structure is consistent with it having DNA binding capabilities [32, 33] . We find that addition of EtBr, at concentrations that disrupt DNA-PK, does not significantly disrupt the interactions between ligase IV and either DNA-PKcs, Ku, or XRCC4 (Fig. 2 ), suggesting the interactions between ligase IV and DNA-PKcs, Ku, and XRCC4 are direct and not mediated by DNA. The DNA binding activity of XRCC4 may contribute to the overall stability of the ligase IV/XRCC4-DNA-PK complex on DNA but it is not required for the individual protein interactions.
Further, the dissociation of DNA-PKcs from Ku does not separate the ligase activity from either Ku or DNA-PKcs, indicating that ligase IV/XRCC4 can associate with Ku and DNA-PKcs independently. This is further supported by the persistent association of ligase IV with Ku in extracts from cells deficient for DNA-PKcs (M059J), although the 20 levels of ligase are significantly reduced in the absence of DNA-PKcs (Fig. 3B, lane 3) .
This reduction may be due to the failure of the holo-complex to form without DNA-PKcs, or to a reduced stability of the Ku/ligase IV/XRCC4 complex relative to the holocomplex. Thus, in cell extracts and in vitro, DNA-PKcs greatly enhances the association of ligase IV/XRCC4 with Ku, suggesting that DNA-PKcs either stabilizes the DNA-PK ligase IV/XRCC4 complex or is required for its assembly.
The NHEJ pathway has been reported to involve exonuclease, helicase, and polymerase activities [1] . Some of the proteins implicated in providing these functions include FEN-1 [34] , MRE11 [35] , Werner Syndrome protein (WRN) [36, 37] , and DNA polymerase alpha [38] . Although, the requirement for DNA-PK and ligase IV/XRCC4 in NHEJ has been clearly characterized by many genetic and biochemical studies [1] [2] [3] [4] [5] , the exact function(s) of DNA-PK in NHEJ remains unclear. It has been suggested that DNA-PK facilitates NHEJ by tethering DNA termini in close proximity [25] , or that DNA-PK may function as a scaffold to recruit and assemble NHEJ enzymes to promote DNA repair [36, 37] . It is clear that NHEJ repair requires many proteins and enzymatic events to function properly. The coordination of these repair enzymes, and the sequence of repair events, must be pivotal for efficient repair of DSBs. The spatial and temporal coordination of repair events is almost certainly mediated by protein-protein interactions at the site of the DSB. We show here that the ligase IV/XRCC4 complex can interact 21 independently with both DNA-PKcs and Ku. We also show that there is specificity to the interactions between DNA-PK and ligase IV/XRCC4, in that Ku interacts predominantly with ligase IV while DNA-PKcs interacts more strongly with XRCC4. Additionally, in the absence of DNA-PKcs the association of ligase IV with Ku is significantly reduced, indicating that both the DNA-PKcs/XRCC4 and the Ku/ligase IV interactions are required for stable association of DNA-PK and ligase IV/XRCC4. These sets of interactions may ensure the correct orientation of the ligase molecule on the DNA-PK scaffold relative to the DNA. Alternatively, if the assembled DNA-PK complex is required for stable association of the ligase IV/XRCC4 complex, then the assembly of DNA-PK must precede the localization of ligase IV to the DSB. In this manner DNA-PK may temporally regulate the assembly of the NHEJ repair machinery. Identification of other NHEJ components and definition of their interactions with DNA-PK, will be central to a complete understanding of the molecular mechanism of NHEJ. 
